No association of IL-12p40 pro1.1 polymorphism with juvenile idiopathic arthritis

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • C.S. Eberhardt - , Geneva University Hospitals (Author)
  • J.P. Haas - , German Center for Pediatric and Adolescent Rheumatology (Author)
  • H. Girschick - , Vivantes Hospitals Berlin (Author)
  • T. Schwarz - , University Hospital of Würzburg (Author)
  • H. Morbach - , University Hospital of Würzburg (Author)
  • A. Rösen-Wolff - , Department of Paediatrics (Author)
  • D. Foell - , University of Münster (Author)
  • G. Dannecker - , Klinikum Stuttgart (Author)
  • C. Schepp - , University Hospital Regensburg (Author)
  • G. Ganser - , St.-Josef-Stift Sendenhorst (Author)
  • N. Honke - , University Hospital Aachen (Author)
  • T. Eggermann - , University Hospital Heidelberg (Author)
  • J. Müller-Berghaus - , Paul-Ehrlich-Institut (Author)
  • N. Wagner - , University Hospital Aachen (Author)
  • K. Ohl - , University Hospital Aachen (Author)
  • K. Tenbrock - , University Hospital Aachen (Author)

Abstract

Background
IL-12p40 plays an important role in the activation of the T-cell lines like Th17 and Th1-cells. Theses cells are crucial in the pathogenesis of juvenile idiopathic arthritis. A polymorphism in its promoter region and the genotype IL12p40 pro1.1 leads to a higher production of IL-12p40. We studied whether there is a difference in the distribution of the genotype in patients with JIA and the healthy population.

Methods
In 883 patients and 321 healthy controls the IL-12p40 promoter genotype was identified by ARMS-PCR.

Results
There is no association of IL-12p40 pro polymorphism neither in patients with JIA compared to controls nor in subtypes of JIA compared to oligoarthritis. We found a non-significant tendency of a higher prevalence of the genotype pro1.1 in systemic arthritis (32.4 %) and in rheumatoid factor negative polyarthritis (30.5 %) and a lower pro1.1 genotype in persistent oligoarthritis (20.7 %) and in enthesitis-related arthritis (17 %). Likelihood of the occurrence of genotype IL12-p40 pro1.1 in patients with systemic arthritis (OR 1.722, CI 95 % 1.344-2.615, p 0.0129) and RF-negative polyarthritis (OR 1.576, CI 95 % 1.046-2.376, p 0.0367) compared to persistent oligoarthritis was significantly higher. This was also true for comparison of their homozygous genotypes IL-12p40 pro 1.1 and 2.2 in systemic arthritis (OR 1.779, CI 95 % 1.045-3.029, p 0.0338). However, in Bonferroni correction for multiple hypothesis this was not significant.

Conclusion
A tendency of a higher prevalence of the genotype IL-12p40 pro1.1 in systemic arthritis and in rheumatoid factor negative polyarthritis was observed but not significant. Further investigations should be done to clarify the role IL-12p40 in the different subtypes of JIA.

Details

Original languageEnglish
Article number61
JournalPediatric rheumatology online journal
Volume13
Issue number1
Publication statusPublished - 15 Dec 2015
Peer-reviewedYes

External IDs

Scopus 84949649676

Keywords